Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05856149 · ClinicalTrials.gov registry record · NA
Mobile Diabetes Prevention for Hispanics Living in Rural Areas
A NA study, sponsored by ISA Associates.
- Completed
- Registry status
- NA
- Development phase
- 179
- Enrollment target
NCT05856149: Completed NA study, sponsored by ISA Associates.
NCT05856149 is a NA study that has completed, run by ISA Associates. The registered enrollment target is 179 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05856149, a NA study, has completed, sponsored by ISA Associates.
- COMPLETED
- Registry status
- NA
- Development phase
- 179 participants
- Enrollment target
Study Summary
The goal of this Randomized Controlled Trial (RCT) is to test the effectiveness of a mobile, web-based diabetes prevention program for Hispanics living in rural communities. The main question it aims to answer is: Does STEPS, a mobile, web-based diabetes prevention program, reduce the risk of Type II Diabetes in rural Hispanics compared to usual care? Participants will be randomly assigned to receive either the mobile STEPS intervention or usual care for a total of three months. Researchers will compare percentage weight loss, and additional outcome measures in participants of both groups at months three and six post-baseline.
Primary Outcome
Weight will be assessed using a scale at study visits. Research staff will then use this number to calculate percent weight loss over time.
Interventions
- BEHAVIORAL Mobile Diabetes Prevention Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 179 participants |
| Start Date | 2023-04-19 |
| Est. Completion | 2025-01-31 |
| Phase | NA |
What the finished NCT05856149 record still lists
NCT05856149 is an interventional study that assigns participants to a tested intervention. The registered 179 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 1 intervention - of which Mobile Diabetes Prevention Program is the first listed.
NCT05856149 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05856149 about?
NCT05856149 is a clinical study titled "Mobile Diabetes Prevention for Hispanics Living in Rural Areas". The goal of this Randomized Controlled Trial (RCT) is to test the effectiveness of a mobile, web-based diabetes prevention program for Hispanics living in rural communities. The main question it aims to answer is: Does STEPS, a mobile, web-based diabetes prevention program, reduce the risk of Type I...
What is the current status of trial NCT05856149?
This trial is currently completed. It is a NA study. The enrollment target is 179 participants. The study started on 2023-04-19. Estimated completion is 2025-01-31.
What interventions are being tested in trial NCT05856149?
The interventions under investigation include: Mobile Diabetes Prevention Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT05856149?
This trial is sponsored by ISA Associates, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05856149's enrollment target sits among peer trials
179 604th of 2000 higher than 1,397 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06581198 · 179 participants · Phase 2
A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)
- NCT07356323 · 179 participants · NA
A Prospective, Single-arm, Trial to Determine Contamination Rates When Using an Antibacterial Incise Drape During Orthopedic Surgery
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI